PONTE VEDRA, Fla., Dec. 11, 2025 -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing transformative therapeutics to overcome the limitations of current anticoagulation therapy, today announced the acquisition...
Venture Partner Mike Grey named EY Entrepreneur Of The Year San Diego
News | 06. 24. 2014
Venture Partner Mike Grey named EY Entrepreneur Of The Year San Diego
